Repositorio de Universidad Autónoma de Chile.
metadata only
Masitinib for the treatment of mild to moderate Alzheimer's disease
Alzheimer's disease (AD) is a degenerative neurological disorder that is the most common cause of dementia and disability in older patients. Available treatments are symptomatic in nature and are only sufficient to improve the quality of life of AD patients temporarily. A potential strategy, current
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Comprehensive Support for Alzheimer's Disease Caregivers#896819
- PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease#1032455
- Comparative Study Between Alzheimer's and Multi-infarct Dementia#992738
- The Promise and Peril of Alzheimer Disease Prevention.#388642
- TB006 Expanded Access (EA) Compassionate Use#841683
Record · ID 948710
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive